Furthermore, the PIWIL4/SUPT5H complex has been identified as a promising prognostic biomarker for predicting clinical outcomes and immune microenvironment features in intrahepatic cholangiocarcinoma (54). Here, PIWIL4 is linked to intrahepatic cholangiocarcinoma.